UL Solutions Inc. (ULS): what the price assumes

In the published model solve dated 2026-Q2, anchored at $79.18, UL Solutions Inc. (ULS) is priced for today's economics sustained for ~13.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/ULS

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Solve inputs: computed at a 8.8% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.4 years.

How unusual the bet is: high

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=15)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Roughly a third of revenue comes from work customers cannot stop buying without redesigning their products, because "To maintain the right to use our certification marks, including the UL Mark, and meet certain regulatory requirements, our customers must meet certain certification program requirements, including mandatory inspection and monitoring".
• The gap between what the price needs and what the business is delivering is the whole risk: the consumer-facing segment carrying the premium grew organic revenue 3.0% in the March 2026 quarter, while the price embeds growth pinned at a self-funding ceiling of about 25% a year for roughly 14 years.
• Second-quarter results are scheduled for August 4, 2026, and the organic rate in the consumer segment is the line that matters in them.

Bull Case

Take the strongest objection first, because it is genuinely strong. Today's price only makes arithmetic sense if this business compounds at an unusual rate for well over a decade, and the most recent quarter shows the consumer-facing segment growing organic revenue in the low single digits. On its face that is a mismatch big enough to end the discussion. The question worth asking is whether the objection is aimed at the right part of the company.

What UL Solutions sells is not really testing. It sells permission. "Ongoing Certification Services (approximately 33% of revenue)" exists for a specific reason: "To maintain the right to use our certification marks, including the UL Mark, and meet certain regulatory requirements, our customers must meet certain certification program requirements, including mandatory inspection and monitoring". A manufacturer that stops paying does not simply lose a supplier. It loses the mark on the packaging, which means renegotiating with retailers, regulators and insurers who all treat that mark as the entry ticket. The switching cost is not the invoice. It is the product itself, and often the shelf.

The front end of that annuity funds itself. The annual report describes how "Certification testing services generally align with the new product development cycle and help customers mitigate risk, demonstrate compliance with regulatory requirements and deliver confidence to businesses and consumers", and it sizes that front end at "Certification Testing (approximately 28% of revenue)". Every new product a customer launches walks through the testing door and then, if it passes, joins the maintained-certification base behind it. Growth in the recurring line is a lagging function of the new-product work done two and three years earlier, which is a slower and duller mechanic than a software land-and-expand motion, and considerably harder for a competitor to interrupt.

The economics look like what that description implies. Trailing operating profit is $542 million on $3.11 billion of revenue, and free cash flow runs about $450 million a year against modest stock compensation. EXPO, the nearest listed comparison, earns a 19.4% operating margin on $602.8 million of revenue while growing revenue 7.8%; UL Solutions is running a similar margin structure at five times the scale, and it keeps adding physical capacity where regulation creates demand, most recently an automotive electromagnetic compatibility laboratory opened in Toyota City in June 2026. Laboratories, accreditations and inspector networks are slow to build and therefore slow to compete away. That durability, not the current growth rate, is what a buyer at this price is actually underwriting.

Bear Case

Start with who owns the shares and what they may do with them, because the capital structure here is unusual and it works against the holder in two directions at once. The share count has been drifting upward, about 0.7% a year over the three years to March 2026, so the per-share denominator grows rather than shrinks. Above that sits a controlling nonprofit stockholder, and the annual report is explicit about both consequences: concentrated control may "prevent investors from realizing any change-of-control premium on shares of our common stock that may otherwise accrue to UL Standards & Engagement", and "UL Standards & Engagement may pursue such sales to raise proceeds for its public safety mission or if it otherwise determines a sale transaction is in its best interests". The two normal ways an expensively priced stock gets rescued, a buyer paying a premium or a shrinking float, are both blocked, while a large potential seller sits above the market. Borrowings are small and comfortably serviced; leverage is not the fragility. Supply and control are.

That matters because the price needs a very long runway. The consumer-facing segment carries the priced-in premium, and what the price embeds is growth held at the fastest rate the business could fund from its own profits, around 25% a year, sustained for something like 14 years. What that segment actually reported for the March 2026 quarter was this: "revenue increased $9 million, or 3.0%, primarily due to growth in Certification Testing revenue of $5 million across most industries, driven primarily by continued demand for consumer technology". Nine million dollars. The distance between three percent and the ceiling rate is not a rounding issue, and duration makes it worse rather than better: of the fast growers this has been measured against, only about 14% held a comparable pace even ten years.

Two structural exposures sit under the franchise itself. The first is that the company tests against standards written by its own controlling stockholder, and the filing acknowledges what that can do to customers: they must "comply with the requirements of the UL Standards & Engagement standards, which could increase our customers' costs and delay market entry of the products. Affected customers may take actions that negatively affect our business". A customer who concludes the referee and the rulebook share an owner has an incentive to route work to a competing laboratory. The second is that the asset being sold is a mark, and marks get copied: in June 2026 the company issued a public notice about unauthorized UL certification marks appearing on water-based fire extinguishers. Every counterfeit that reaches a shelf without incident makes the paid version look slightly more optional.

If the long runway does not materialize, there is very little underneath. The price sits about 49% above where the peer-multiple methods land and roughly 4.3 times above where the earnings-power methods land, and the only family that reaches today's quote at all is the forward-growth one. The closest of those only reaches the quote on the assumption that today's enterprise-value-to-earnings multiple never compresses at any point in the projection, which treats the market's current willingness to pay as a permanent feature. The bet is also sensitive to the discount rate in a way that compounds the duration problem: each additional percentage point of cost of capital removes roughly two and a half years from the horizon the price can support. A company earning $542 million of operating profit is not going to fail. It is simply being priced as though the next decade and a half is already known.

Valuation

The clearest statement of what $85.49 is paying for sits in one segment rather than in the whole company. The consumer-facing business is the piece carrying the priced-in premium, and the price embeds its operating profit growing at the fastest pace it could fund from its own earnings, roughly 25% a year, held there for about 14 years. That is computed at about an 8.9% cost of capital, and it is one solve under fixed assumptions rather than a measurement, so treat the horizon as an order of magnitude. The shape of the demand is what matters: the price is not asking for a step change in profitability. It is asking for an ordinary rate of compounding to last an extraordinary length of time.

Two reference points put that in proportion. The multiple sits at the very top of the peer distribution, well beyond the upper quartile. And among comparable fast growers, roughly 14% managed to keep a pace at this level going across a full decade. The confidence attached to this read is high, which is worth knowing because it is not always.

The methods split unusually cleanly. Only the forward-growth family reaches today's price. Peer multiples land about 49% below it, and the earnings-power methods land roughly 4.3 times below. When the spread has that shape, the price is not a mispricing claim in either direction; it is a durability premium that the static approaches structurally cannot express, because none of them has a way to charge for a franchise lasting longer than its cash flows.

The mechanisms behind the two extremes are worth naming plainly. The earnings-power lens takes a three-year average of operating profit and capitalizes it as though the company never grows again, which for a business whose recurring base accumulates year after year is a floor rather than a valuation. At the other end, the cash-flow method that comes closest to today's price only gets close because its exit multiple is held at today's level for the whole projection window. That is an input rather than a result, and it is the input doing most of the work. The sensitivity is direct: each additional percentage point of cost of capital takes roughly two and a half years off the horizon the price supports.

The underlying business is legible and the balance sheet is quiet. Revenue divides into "Certification Testing (approximately 28% of revenue)", "Ongoing Certification Services (approximately 33% of revenue)", non-certification testing and advisory work, and a small software line, so about six dollars in every ten come from certification activity of one kind or another. Trailing operating profit of $542 million covers interest expense more than thirteen times over, which makes the solvency question close to academic. Net of cash, borrowings stand at 233 million dollars, and the share count is edging up rather than down. Nothing in that picture threatens the company. It simply means nothing in that picture defends the price either; the horizon does all the defending.

Catalysts

The next scheduled event is second-quarter results on August 4, 2026, a date the company set publicly on July 21, 2026. The line to read first is the organic growth rate in the consumer-facing segment, which the last quarterly filing put at 3.0% for the three months to March 31, 2026, with certification testing contributing five million dollars of that increase on demand for consumer technology. That rate, rather than the consolidated total, is what the current price is built around.

Two company actions in June bear on the operating story in opposite directions. On June 17, 2026 the company opened an advanced automotive electromagnetic compatibility testing laboratory in Toyota City, Japan, which is capacity added exactly where vehicle electrification and regulatory testing requirements are expanding, and the kind of investment whose revenue shows up over years rather than quarters. On June 30, 2026 the company issued a public notice about unauthorized UL certification marks found on water-based fire extinguishers. Counterfeit marks are a direct attack on the asset the whole business rests on, and policing them is a cost with no revenue attached.

The sell side has been moving toward the bull view: UBS upgraded the stock to Buy from Neutral on July 14, 2026, framing the company as a high-quality compounder. That framing is consistent with what the price already assumes rather than a challenge to it, which is the thing to keep in view. The report in August will either narrow the gap between the delivered growth rate and the embedded one or widen it, and there is not much in between.

Peer Cohorts (Per Segment, With Filing Citations)

Industrial / Consumer / Software and Advisory (reported)

• EXPO (EXPONENT, INC.)
• FY2025 10-K: …clients design safer, more reliable, and higher‑performing products. As advanced materials and electrochemical technologies have become increasingly central to modern devices, understanding how they function - and fail - is essential to ensuring product safety, durability, and competitive performance. 7 We apply…
• FY2025 10-K: …future failures of new products as well as current construction and aging infrastructure. Over the past year, our Metallurgical & Corrosion Engineering Practice helped clients solve critical materials-related issues in the transportation, energy, utilities, infrastructure, medical device, and chemical processing…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.